Source avec lien : LAWSON, Christina C., JOHNSON, Candice Y., NASSAN, Feiby L.[et al.], « CE: Original Research: Antineoplastic Drug Administration by Pregnant and Nonpregnant Nurses: An Exploration of the Use of Protective Gloves and Gowns », AJN The American Journal of Nursing, vol. 119 / 1, janvier 2019, p. 28.
Voir aussi : Protective Glove and Gown Use When Administering Antineoplastic Drugs
De nombreux médicaments antinéoplasiques (chimiothérapeutiques) sont des cancérogènes connus ou probables pour l’homme, et beaucoup se sont avérés toxiques pour la reproduction. Il est recommandé aux infirmières qui manipulent ou administrent de tels médicaments de porter au minimum des gants doubles et une blouse non absorbante pour se protéger. Mais on ignore dans quelle mesure les infirmières le font, c’est pourquoi cette nouvelle étude de NIOSH évalue l’utilisation de gants et de blouses par des infirmières enceintes et non-enceintes qui administrent des médicaments antinéoplasiques aux États-Unis et au Canada.
Background: Many antineoplastic (chemotherapeutic) drugs are known or probable human carcinogens, and many have been shown to be reproductive toxicants in cancer patients. Evidence from occupational exposure studies suggests that health care workers who have long-term, low-level occupational exposure to antineoplastic drugs have an increased risk of adverse reproductive outcomes. It’s recommended that, at minimum, nurses who handle or administer such drugs should wear double gloves and a nonabsorbent gown to protect themselves. But it’s unclear to what extent nurses do.
Purpose: This study assessed glove and gown use by female pregnant and nonpregnant nurses who administer antineoplastic drugs in the United States and Canada.
Methods: We used data collected from more than 40,000 nurses participating in the Nurses’ Health Study 3. The use of gloves and gowns and administration of antineoplastic drugs within the past month (among nonpregnant nurses) or within the first 20 weeks of pregnancy (among pregnant nurses) were self-reported via questionnaire.
Results: Administration of antineoplastic drugs at any time during their career was reported by 36% of nonpregnant nurses, including 27% who reported administering these drugs within the past month. Seven percent of pregnant nurses reported administering antineoplastic drugs during the first 20 weeks of pregnancy. Twelve percent of nonpregnant nurses and 9% of pregnant nurses indicated that they never wore gloves when administering antineoplastic drugs, and 42% of nonpregnant nurses and 38% of pregnant nurses reported never using a gown. The percentage of nonpregnant nurses who reported not wearing gloves varied by type of administration: 32% of those who administered antineoplastic drugs only as crushed pills never wore gloves, compared with 5% of those who administered such drugs only via infusion.
Conclusion: Despite longstanding recommendations for the safe handling of antineoplastic and other hazardous drugs, many nurses—including those who are pregnant—reported not wearing protective gloves and gowns, which are considered the minimum protective equipment when administering such drugs. These findings underscore the need for further education and training to ensure that both employers and nurses understand the risks involved and know which precautionary measures will minimize such exposures.